tiprankstipranks
The United Laboratories International Holdings Limited (ULIHF)
OTHER OTC:ULIHF
US Market
ULIHF
The United Laboratories International Holdings
RESEARCH TOOLSreports
Want to see ULIHF full AI Analyst Report?

The United Laboratories International Holdings (ULIHF) Income Statement

20 Followers

The United Laboratories International Holdings Income Statement

Last quarter (Q4 2025), The United Laboratories International Holdings's total revenue was ¥5.60B, a decrease of -18.09% from the same quarter last year. In Q4, The United Laboratories International Holdings's net income was ¥188.39M. See The United Laboratories International Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 12.87B¥ 13.76B¥ 13.74B¥ 11.33B¥ 9.70B
Gross Profit
¥ 5.37B¥ 6.08B¥ 6.33B¥ 4.97B¥ 4.21B
Operating Expenses
¥ 3.16B¥ 3.23B¥ 3.05B¥ 2.95B¥ 2.80B
Depreciation and Amortization
¥ 632.73M¥ 538.01M¥ 565.65M¥ 523.67M¥ 596.06M
EBITDA
¥ 2.84B¥ 3.35B¥ 3.98B¥ 2.54B¥ 1.98B
Operating Income
¥ 2.21B¥ 3.12B¥ 3.29B¥ 2.02B¥ 1.41B
Other Income/Expenses
¥ 251.08M¥ 172.58M¥ 54.83M¥ -18.31M¥ -208.75M
Pretax Income
¥ 2.46B¥ 3.29B¥ 3.34B¥ 2.01B¥ 1.20B
Net Income
¥ 2.03B¥ 2.66B¥ 2.70B¥ 1.58B¥ 988.10M
Per Share Metrics
Basic EPS
¥ 1.08¥ 1.46¥ 1.49¥ 0.87¥ 0.54
Diluted EPS
¥ 1.08¥ 1.46¥ 1.49¥ 0.87¥ 0.54
Weighted Average Shares Outstanding
 1.89B 1.82B 1.82B 1.82B 1.84B
Weighted Average Shares Outstanding (Diluted)
 1.89B 1.82B 1.82B 1.82B 1.84B
Currency in CNY

The United Laboratories International Holdings Earnings and Revenue History